IP Library Granted Patent US 9,375,491
Granted Patent B2
US 9,375,491 · App. 14/354,471 · Granted Jun 28, 2016

Chimeric promoter for cone photoreceptor targeted gene therapy

Inventors: Sanford Leon Boye (Gainesville, FL); Frank Markus Dyka (Gainesville, FL); William W. Hauswirth (Gainesville, FL)
Assignee: University of Florida Research Foundation, Inc.
A61K48/005C12N15/86C12N2750/14143C12N2830/008C12N2830/85
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,375,491
App. No.
14/354,471
Granted
Jun 28, 2016
Kind
B2
Abstract

The subject invention concerns materials and methods for providing for cone cell specific expression of a polynucleotide in a human or animal. One aspect of the invention concerns a polynucleotide promoter sequence that directs expression of an operably linked polynucleotide in cone cells. In one embodiment, a polynucleotide of the invention comprises a nucleotide sequence of an interphotoreceptor retinoid-binding protein (IRBP) gene that is positioned upstream of a promoter nucleotide sequence of a cone transducin alpha-subunit (GNAT2) gene. Another aspect of the subject invention concerns methods for expressing a selected polynucleotide in cone cells. The selected polynucleotide can be provided in a polynucleotide of the invention wherein the selected polynucleotide is operably linked to a polynucleotide promoter sequence of the invention. In one embodiment, the selected polynucleotide sequence is provided in a polynucleotide vector of the invention. The vector comprising the selected polynucleotide is then introduced into a cell. The selected polynucleotide is expressed only in cone cells, with very little, if any, expression in rods or other cells. A selected polynucleotide can be one that encodes, for example, a therapeutic protein or a functional protein that is defective or underexpressed in the targeted cone cells.

Claims (5)

1. A polynucleotide that promotes expression in cone cells of an operably linked nucleotide sequence, wherein said polynucleotide comprises an enhancer nucleotide sequence of an interphotoreceptor retinoid-binding protein (IRBP) gene sequence that is positioned upstream of a promoter nucleotide sequence of a cone transducing alpha-subunit (GNAT2) gene sequence, wherein said polynucleotide sequence comprises the nucleotide sequence shown in SEQ. ID NO:1 or SEQ. ID NO:4.

2. The polynucleotide according to claim 1 , wherein said polynucleotide further comprises a nucleotide sequence encoding a therapeutic protein or a functional protein or a reporter protein.

3. The polynucleotide according to claim 2 , wherein said polypeptide is a cyclic nucleotide-gated (CNG) channel polypeptide.

4. The polynucleotide according claim 3 , wherein said CNG polypeptide is a CNGA3 or a CNGB3 polypeptide.

5. The polynucleotide according to claim 4 , wherein said CNG3B polypeptide comprises the amino acid sequence of SEQ ID NO:5.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 16, 2015
From: UNIVERSITY OF FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035444/0361 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2015
From: BOYE, SANFORD LEON; DYKA, FRANK MARKUS; HAUSWIRTH, WILLIAM W.
To: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
Reel/Frame 035125/0919 →
Continuity (2)
Provisional Application 61552975 · Oct 28, 2011
Related Publication 20140275231A1 · Sep 18, 2014